-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Upgrades Relay Therapeutics to Overweight, Raises Price Target to $13

Benzinga·12/12/2025 16:31:54
語音播報
Wells Fargo analyst Eva Fortea Verdejo upgrades Relay Therapeutics (NASDAQ:RLAY) from Equal-Weight to Overweight and raises the price target from $6 to $13.